What is it about?
This study presents Brazil’s first national consensus on lipedema. Using the Delphi method, 113 experts created evidence-based guidelines to improve diagnosis, treatment, and awareness of this underrecognized condition.
Featured Image
Why is it important?
Lipedema is often misdiagnosed as obesity or lymphedema, leading to improper treatment and patient suffering. This consensus is a critical step in standardizing care, reducing stigma, and promoting earlier diagnosis and multidisciplinary, evidence-based treatment strategies in Brazil
Perspectives
The consensus highlights the need for more research on lipedema’s causes, diagnostics, and long-term treatment outcomes. It encourages collaboration among clinicians, researchers, and patients to refine therapies and improve quality of life. Future efforts should focus on validating clinical tools, exploring genetic links, and strengthening international collaboration
Professor Alexandre CM Amato
Universidade de Santo Amaro
Read the Original
This page is a summary of: Brazilian Consensus Statement on Lipedema using the Delphi methodology, Jornal Vascular Brasileiro, January 2025, FapUNIFESP (SciELO),
DOI: 10.1590/1677-5449.202301832.
You can read the full text:
Contributors
The following have contributed to this page
